Navigating the EU Clinical Trials Regulation (CTR)
The European Union Clinical Trials Regulation (EU CTR) represents a landmark shift in the regulation of clinical research within the EU. Enacted to streamline and harmonize the conduct of clinical trials across member states, the CTR aims to enhance patient safety, promote transparency, and facilitate the timely initiation and completion of clinical research. As the […]
The EU IVDR Impact on Clinical Trials
The European Union In Vitro Diagnostic Regulation (EU IVDR) stands as a pivotal framework shaping the landscape of medical device regulation within the EU. While primarily targeting in vitro diagnostic (IVD) devices, its ramifications extend beyond mere device certification. Among its ripple effects lies a significant impact on clinical trials, particularly those involving IVDs. Understanding […]
ANVISA’s Recognition of Decisions by International Regulators: Facilitating Access to Medical Devices in Brazil
In the realm of healthcare, access to safe and effective medical devices is paramount to ensuring quality patient care. Brazil, as one of the largest healthcare markets in the world, has been taking significant strides to streamline its regulatory processes and facilitate the entry of medical devices that have been approved by reputable international regulatory […]
